Fischer Medical partners with Indonesia's PT Pariko to support TB eradication; Stock rises

Fischer Medical Ventures Partners with Indonesian Entity for Tuberculosis Eradication

Fischer Medical Ventures Ltd.'s shares surged by as much as 5% on Monday, December 1, following the announcement of a partnership between its subsidiary, Time Medical International Ventures (India) Private Limited, and PT Pharmindo Rimpang Kokoh ("PT Pariko") to combat tuberculosis in Indonesia.

• The collaboration aims to utilize portable, AI-powered X-ray systems in the city of Jember, Indonesia.
• A $6.5 million contract has been signed to supply 250 units of these systems.
• Fischer Medical Ventures expects the deal to position the company as a strategic partner in Indonesia's public healthcare initiatives.

Key Details of the Partnership:

• Contract duration: The contract is for a pilot phase, set to be executed and delivered in tranches by March 2026.
• Supply: 250 portable, AI-powered X-ray systems will be provided to the city of Jember, Indonesia.

Company Performance:

Fischer Medical Ventures has reported a net profit of ₹84 lakh in the September quarter, marking an improvement from its net loss during the same period last year.

Revenue for the quarter increased by 64% on a year-on-year basis.

Share Performance:

Fischer Medical Ventures' shares are trading 3% higher on Monday at ₹49.55.

The stock has risen in five out of the last six sessions, but has declined 36% so far in 2025.